Cargando…
Personalized antihypertensive treatment guided by pharmacogenomics in China
BACKGROUND: The implementation of genotyping for anti-hypertensive drugs in clinical practice remains a challenge. We conducted this study to analyze the distribution of polymorphisms of antihypertensive drug-related genes in Changsha County in China and compare the clinical effectiveness of genotyp...
Autores principales: | Xiao, Zhi-Lin, Yang, Mei, Chen, Xiao-Bin, Xie, Xiu-Mei, Chen, Mei-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622397/ https://www.ncbi.nlm.nih.gov/pubmed/36329971 http://dx.doi.org/10.21037/cdt-22-154 |
Ejemplares similares
-
Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen
por: Wigle, Theodore J., et al.
Publicado: (2017) -
Using a pharmacogenomic algorithm to guide the treatment of depression
por: Hall-Flavin, D K, et al.
Publicado: (2012) -
Pharmacogenomics and Personalized Medicine
por: Cecchin, Erika, et al.
Publicado: (2020) -
Antihypertensive Action of Allantoin in Animals
por: Chen, Mei-Fen, et al.
Publicado: (2014) -
Atenolol Induced HDL-C Change in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study
por: McDonough, Caitrin W., et al.
Publicado: (2013)